Lung remodeling and pulmonary hypertension after myocardial infarction: Pathogenic role of reduced caveolin expression

Cardiovascular Research

Volumn 63, Issue 4, 2004, Pages 747-755

  Jasmin, Jean François ^a   Mercier, Isabelle ^a   Hnasko, Robert ^a   Cheung, Michelle W C ^a   Tanowitz, Herbert B ^a   Dupuis, Jocelyn ^b   Lisanti, Michael P ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MONTREAL HEART INSTITUTE   (Canada)

Author keywords

Caveolin proteins; Cyclins; Lung remodeling; Myocardial infarction; Pulmonary hypertension

Indexed keywords

CAVEOLIN 1; CAVEOLIN 2; CYCLIN D1; CYCLIN D3; STAT3 PROTEIN; TYROSINE;

ANESTHESIA; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; HEART INFARCTION; HEART RIGHT VENTRICLE HYPERTROPHY; HEMODYNAMICS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; MALE; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY HYPERTENSION; RAT; UPREGULATION;

ANIMALS; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CAVEOLINS; CYCLIN D1; CYCLINS; DNA-BINDING PROTEINS; HYPERTENSION, PULMONARY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG; MALE; MICE; MICE, KNOCKOUT; MODELS, ANIMAL; MYOCARDIAL INFARCTION; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 4043151526     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2004.05.018     Document Type: Article

References (34)

1. Butler J., Chomsky D.B., Wilson J.R. Pulmonary hypertension and exercise intolerance in patients with heart failure. J. Am. Coll. Cardiol. 34:1999;1802-1806
2. Ghio S., Gavazzi A., Campana C., Inserra C., Klersy C., Sebastiani R., et al. Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J. Am. Coll. Cardiol. 37:2001;183-188
3. Abramson S.V., Burke J.F., Kelly J.J. Jr., Kitchen J.G. III, Dougherty M.J., Yih D.F., et al. Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann. Intern. Med. 116:1992;888-895
4. Jasmin J.F., Calderone A., Leung T.K., Villeneuve L., Dupuis J. Lung structural remodeling and pulmonary hypertension after myocardial infarction: complete reversal with irbesartan. Cardiovasc. Res. 58:2003;621-631
5. Kapanci Y., Burgan S., Pietra G.G., Conne B., Gabbiani G. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension. Am. J. Pathol. 136:1990;881-889
6. Razani B., Schlegel A., Lisanti M.P. Caveolin proteins in signaling, oncogenic transformation and muscular dystrophy. J. Cell Sci. 113:2000;2103-2109
7. Lisanti M.P., Scherer P.E., Tang Z.L., Sargiacomo M. Caveolae, caveolin and caveolin-rich membrane domains: a signalling hypothesis. Trends Cell Biol. 4:1994;231-235
8. Okamoto T., Schlegel A., Scherer P.E., Lisanti M.P. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273:1998;5419-5422
9. Smart E.J., Graf G.A., McNiven M.A., Sessa W.C., Engelman J.A., Scherer P.E., et al. Caveolins, liquid-ordered domains, and signal transduction. Mol. Cell. Biol. 19:1999;7289-7304
10. Rothberg K.G., Heuser J.E., Donzell W.C., Ying Y.S., Glenney J.R., Anderson R.G. Caveolin, a protein component of caveolae membrane coats. Cell. 68:1992;673-682
11. Glenney J.R., Soppet D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. Proc. Natl. Acad. Sci. 89:1992;10517-10521
12. Scherer P.E., Okamoto T., Chun M., Nishimoto I., Lodish H.F., Lisanti M.P. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. 93:1996;131-135
13. Tang Z., Scherer P.E., Okamoto T., Song K., Chu C., Kohtz D.S., et al. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271:1996;2255-2261
14. Scherer P.E., Lewis R.Y., Volonte D., Engelman J.A., Galbiati F., Couet J., et al. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272:1997;29337-29346
15. Song K.S., Li S., Okamoto T., Quilliam L.A., Sargiacomo M., Lisanti M.P. Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains. J. Biol. Chem. 271:1996;9690-9697
16. Razani B., Engelman J.A., Wang X.B., Schubert W., Zhang X.L., Marks C.B., et al. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276:2001;38121-38128
17. Razani B., Wang X.B., Engelman J.A., Battista M., Lagaud G., Zhang X.L., et al. Caveolin-2-deficient mice show evidence of severe pulmonary dysfunction without disruption of caveolae. Mol. Cell. Biol. 22:2002;2329-2344
18. Zhao Y.Y., Liu Y., Stan R.V., Fan L., Gu Y., Dalton N., et al. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc. Natl. Acad. Sci. 99:2002;11375-11380
19. Sehgal P.B., Guo G.G., Shah M., Kumar V., Patel K. Cytokine signaling: STATS in plasma membrane rafts. J. Biol. Chem. 277:2002;12067-12074
20. Park D.S., Lee H., Frank P.G., Razani B., Nguyen A.V., Parlow A.F., et al. Caveolin-1-deficient mice show accelerated mammary gland development during pregnancy, premature lactation, and hyperactivation of the Jak2/STAT5a signaling cascade. Mol. Cell. Biol. 13:2002;3430
21. Hulit J., Bash T., Fu M., Galbiati F., Albanese C., Sage D.R., et al. The cyclin D1 gene is transcriptionally repressed by caveolin-1. J. Biol. Chem. 275:2000;21203-21209
22. Williams T.M., Cheung M.W., Park D.S., Razani B., Cohen A., Muller W.J., et al. Loss of caveolin-1 gene expression accelerates the development of dysplastic mammary lesions in tumor-prone transgenic mice. Mol. Cell. Biol. 14:2003;1027-1042
23. Scherer P.E., Tang Z., Chun M., Sargiacomo M., Lodish H.F., Lisanti M.P. Caveolin isoforms differ in their N-terminal protein sequence and subcellular distribution. Identification and epitope mapping of an isoform-specific monoclonal antibody probe. J. Biol. Chem. 270:1995;16395-16401
24. Murata T., Sato K., Hori M., Ozaki H., Karaki H. Decreased endothelial nitric-oxide synthase (eNOS) activity resulting from abnormal interaction between eNOS and its regulatory proteins in hypoxia-induced pulmonary hypertension. J. Biol. Chem. 277:2002;44085-44092
25. Black S.M., Bekker J.M., McMullan D.M., Parry A.J., Ovadia B., Reinhartz O., et al. Alterations in nitric oxide production in 8-week-old lambs with increased pulmonary blood flow. Pediatr. Res. 52:2002;233-244
26. Shi Y., Pritchard K.A. Jr., Holman P., Rafiee P., Griffith O.W., Kalyanaraman B., et al. Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3. Free Radic. Biol. Med. 29:2000;695-703
27. Oka N., Asai K., Kudej R.K., Edwards J.G., Toya Y., Schwencke C., et al. Downregulation of caveolin by chronic beta-adrenergic receptor stimulation in mice. Am. J. Physiol. 273:1997;C1957-C1962
28. Omura T., Yoshiyama M., Ishikura F., Kobayashi H., Takeuchi K., Beppu S., et al. Myocardial ischemia activates the JAK/STAT pathway through angiotensin II signaling in in vivo myocardium of rats. J. Mol. Cell. Cardiol. 33:2001;307-316
29. Ju H., Venema V.J., Liang H., Harris M.B., Zou R., Venema R.C. Bradykinin activates the Janus-activated kinase/signal transducer and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochem. J. 351:2000;257-264
30. Masuda M., Suzui M., Yasumatu R., Nakashima T., Kuratomi Y., Azuma K., et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res. 62:2002;3351-3355
31. Amin H.M., Medeiros L.J., Ma Y., Feretzaki M., Das P., Leventaki V., et al. Inhibition of JAK3 induces apoptosis and decreases anaplastic lymphoma kinase activity in anaplastic large cell lymphoma. Oncogene. 22:2003;5399-5407
32. Shi Y., Pritchard K.A. Jr., Holman P., Rafiee P., Griffith O.W., Kalyanaraman B., et al. Chronic myocardial hypoxia increases nitric oxide synthase and decreases caveolin-3. Free Radic. Biol. Med. 29:2000;695-703
33. Piech A., Massart P.E., Dessy C., Feron O., Havaux X., Morel N., et al. Decreased expression of myocardial eNOS and caveolin in dogs with hypertrophic cardiomyopathy. Am. J. Physiol. Heart Circ. Physiol. 282:2002;H219-H231
34. Fujita T., Toya Y., Iwatsubo K., Onda T., Kimura K., Umemura S., et al. Accumulation of molecules involved in alpha1-adrenergic signal within caveolae: caveolin expression and the development of cardiac hypertrophy. Cardiovasc. Res. 51:2001;709-716